Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

35.34
-0.2000-0.56%
Pre-market: 35.31-0.0300-0.08%07:08 EDT
Volume:326.76K
Turnover:11.48M
Market Cap:2.09B
PE:-303.97
High:35.57
Open:35.31
Low:34.44
Close:35.54
52wk High:40.22
52wk Low:7.34
Shares:59.15M
Float Shares:43.94M
Volume Ratio:0.63
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1163
EPS(LYR):-0.1163
ROE:-2.37%
ROA:-3.73%
PB:5.93
PE(LYR):-303.97

Loading ...

BRIEF-Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
14 hours ago

Stoke Therapeutics grants 129,565 inducement stock options to new employees at $35.54/share

Reuters
·
15 hours ago

Did Stoke's New R&D Chair Appointment Just Reshape Stoke Therapeutics' (STOK) Antisense Strategy Priorities?

Simply Wall St.
·
Yesterday

Stoke Therapeutics CEO to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 09

Stoke Therapeutics appoints Clare Kahn to board of directors

Reuters
·
Apr 08

Stoke Therapeutics Appoints Clare Kahn, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Apr 08

Stoke Therapeutics CMO Barry Ticho sells STOK shares for 0.1 million

Reuters
·
Apr 04

Stoke Therapeutics FY2026 auditor changes; KPMG dismissed and EY appointed

Reuters
·
Mar 28

Stoke Therapeutics General Counsel Jonathan Allan reports STOK common stock disposal worth USD 313,000

Reuters
·
Mar 25

Stock Track | Stoke Therapeutics Soars 5.39% Intraday on Analyst Price Target Hike

Stock Track
·
Mar 20

Stoke Therapeutics Inc : Canaccord Genuity Raises Target Price to $60 From $36

THOMSON REUTERS
·
Mar 20

Stoke Therapeutics Chief Medical Officer Barry Ticho disposes of USD 460,000 in common shares

Reuters
·
Mar 20

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Valneva (VALN) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Mar 19

Stoke Therapeutics files automatic mixed securities shelf

TIPRANKS
·
Mar 19

Stoke Therapeutics Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 19

Stoke Therapeutics Inc : Wedbush Raises Target Price to $38 From $36

THOMSON REUTERS
·
Mar 18

Stoke Therapeutics director Arthur A. Levin disposes of USD 22,264 in common shares

Reuters
·
Mar 18

Stoke Therapeutics grants 58,650 inducement stock options at USD 33.96 exercise price

Reuters
·
Mar 18

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Mar 18

Stock Track | Stoke Therapeutics Plummets 5.62% Intraday on Disappointing Earnings Forecast

Stock Track
·
Mar 17